Mary Laughlin
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation 14
- Acute Myeloid Leukemia Research 2
- Genetics top 2%
- Mesenchymal stem cell research 7
- Chronic Lymphocytic Leukemia Research 5
- Immunology top 10%
- Immune Cell Function and Interaction 5
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments 2
- Oncology top 10%
-
- Transplantation: Methods and Outcomes 5
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Joanne KurtzbergEdward C. HalperinCladd E. StevensClay SmithMichael L. GrahamCarmelita CarrierJanice F. OlsonPablo Rubinstein
- Cited by
- HematologyGeneticsImmunology
- Journals
- Blood (7 papers)Biology of Blood and Marrow Transplantation (4 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Mary Laughlin
27 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Hematology 1.1k
- Genetics 575
- Immunology 390
- Transplantation 47
- Oncology 360
Countries citing papers authored by Mary Laughlin
This map shows the geographic impact of Mary Laughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Laughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Laughlin more than expected).
Fields of papers citing papers by Mary Laughlin
This network shows the impact of papers produced by Mary Laughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Laughlin. The network helps show where Mary Laughlin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary Laughlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2020 | 1 | |
| 3 | 2018 | 1 | |
| 4 | 2017 | 11 | |
| 5 | 2016 | 32 | |
| 6 | 2011 | 23 | |
| 7 | 2010 | 1 | |
| 8 | 2009 | 7 | |
| 9 | "Pharming" endangers teens. | 2008 | 1 |
| 10 | 2008 | 5 | |
| 11 | 2008 | 10 | |
| 12 | 2007 | 14 | |
| 13 | 2005 | 103 | |
| 14 | 2005 | 1 | |
| 15 | 2005 | 4 | |
| 16 | 2003 | 100 | |
| 17 | 2000 | 72 | |
| 18 | 1997 | 13 | |
| 19 | 1997 | 71 | |
| 20 | Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation into Unrelated Recipientsbreakdown → | 1996 | 762 |
About Mary Laughlin
Mary Laughlin is a scholar working on Hematology, Genetics and Transplantation, having authored 28 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (14 papers), Mesenchymal stem cell research (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Immune Cell Function and Interaction (5 papers), Transplantation: Methods and Outcomes (5 papers), Lymphoma Diagnosis and Treatment (3 papers), Acute Myeloid Leukemia Research (2 papers) and Renal Transplantation Outcomes and Treatments (2 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (575 citations) and Immunology (390 citations). Mary Laughlin has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Joanne Kurtzberg, Edward C. Halperin, Cladd E. Stevens, Clay Smith, Michael L. Graham, Carmelita Carrier, Janice F. Olson, Pablo Rubinstein, Nelson J. Chao and John E. Wagner. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Bone Marrow Transplantation and Cytotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.